Prince of Wales Hospital Structural Heart Registry

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-01

Study Completion Date

2030-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Structural heart disease refers to a group of cardiac defects other than coronary artery disease. Structural heart intervention is a rapidly growing field in cardiology. In the past decade, there has been paradigm shift in the management of structural heart disease from conventional open-heart surgery to transcatheter interventions. With increasing evidence supporting structural heart interventions including transcatheter aortic valve implantation or transcatheter edge to edge repair, there has important updates in recent guidelines in treating structural heart disease. Besides, new device innovations bloomed over the past few years and had expanded the possible treatment options for high surgical risk patients. Some breakthrough devices had been approved recently by the US Food and Drug Administration and some other devices are occasionally used on compassionate ground. However, there has been lack of data in structural heart interventions in Asia Pacific regions outside Japan \[8\]. In this study, we would like to analyze the epidemiological trends, patient characteristics, procedural outcomes and clinical outcomes of structural heart interventions, and compare them with historical cohorts, matched cohort receiving medical therapy and matched cohort receiving open heart surgeries.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Surgery and Transcatheter Intervention for Structural Heart Diseases

NCT02917980

Data Collecting and Analyzing of Different Treatment of Structural Heart Diseases

COMPLETED

The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry

NCT07296016

Structural Heart Disease Mitral Valve Regurgitation

NOT_YET_RECRUITING

Structural Heart and Valve Network PROSPECTIVE Registry

NCT03928639

Mitral Valve Regurgitation Heart Failure Heart Valve Disease +2 more

WITHDRAWN

Application of Comprehensive Non-invasive Assessment To Phenotype Tricuspid Regurgitation

NCT07042360

Tricuspid Regurgitation

RECRUITING

Canadian Adult Congenital Heart Disease Intervention Registry

NCT04288596

Atrial Septal Defect Patent Foramen Ovale Tetralogy of Fallot +4 more

NOT_YET_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Structural Heart Abnormality

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Subject

Structural heart intervensions

Structural heart interventions

Intervention Type PROCEDURE

The study allows us to understand the trend of transcatheter interventions in structural heart disease, clinical outcomes and allows the comparison of the outcomes of structural heart interventions to medical therapy and surgery at PWH, and to HA hospitals.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Structural heart interventions

The study allows us to understand the trend of transcatheter interventions in structural heart disease, clinical outcomes and allows the comparison of the outcomes of structural heart interventions to medical therapy and surgery at PWH, and to HA hospitals.

Intervention Type PROCEDURE